Kang Ko

Kang Ko

Auto-generated profile, based on publicly available information

Kang Ko

Department of Psychiatry, National Center for Mental Health, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2020 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
JKJee Wook Kim
Jee Wook Kim
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
JLJun Ho Lee
Jun Ho Lee
KKKang Ko
Kang Ko
FGfor the KBASE Research Group
for the KBASE Research Group
An emerging body of literature has indicated that moderate alcohol intake may be protective against Alzheimer disease (AD) dementia. However, little information is available regarding whether moderate alcohol intake is related to reductions in amyloid-beta (Aβ) deposition, or is protective via amyloid-independent mechanisms in the living human brain. Here we examined the associations of moderate alcohol intake with in vivo AD pathologies, including cerebral Aβ deposition, neurodegeneration of AD-signature regions, and cerebral white matter hyperintensities (WMHs) in the living human brain. The present study was part of the Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s Disease (KBASE), an ongoing prospective cohort study that started in 2014. As of November 2016, 414 community-dwelling individuals with neither dementia nor alcohol-related disorders (280 cognitively normal [CN] individuals and 134 individuals with mild cognitive impairment [MCI]) between 56 and 90 years of age (mean age 70.9 years ± standard deviation 7.8; male, n [%] = 180 [43.5]) were recruited from 4 sites (i.e., 2 university hospitals and 2 public centers for dementia prevention and management) around Seoul, South Korea. All the participants underwent comprehensive clinical assessments comprising lifetime and current histories of alcohol intake and multimodal brain imaging, including [11C] Pittsburgh compound B positron emission tomography (PET), [18F] fluorodeoxyglucose (FDG) PET, and magnetic resonance imaging (MRI) scans. Lifetime and current alcohol intake were categorized as follows: no drinking, <1 standard drink (SD)/week, 1–13 SDs/week, and 14+ SDs/week. A moderate lifetime alcohol intake (1–13 SDs/week) was significantly associated with a lower Aβ positivity rate compared to the no drinking group, even after controlling for potential confounders (odds ratio 0.341, 95% confidence interval 0.163–0.714, p = 0.004). In contrast, current alcohol intake was not associated with amyloid deposition. Additionally, alcohol intake was not related to neurodegeneration of AD-signature regions or cerebral WMH volume. The present study had some limitations in that it had a cross-sectional design and depended on retrospective recall for alcohol drinking history. In this study, we observed in middle- and old-aged individuals with neither dementia nor alcohol-related disorders that moderate lifetime alcohol intake was associated with lower cerebral Aβ deposition compared to a lifetime history of not drinking. Moderate lifetime alcohol intake may have a beneficial influence on AD by reducing pathological amyloid deposition rather than amyloid-independent neurodegeneration or cerebrovascular injury.

1 March 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
SJSo Yeon Jeon
So Yeon Jeon
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
JLJun Ho Lee
Jun Ho Lee
YCYoung Min Choe
Young Min Choe
DLDong Young Lee
Dong Young Lee

14 October 2021 in Neurobiology of Aging
Verified
Journal Article
Open access
KKKang Ko
Kang Ko
DYDahyun Yi
Dahyun Yi
MBMin Soo Byun
Min Soo Byun
JLJun Ho Lee
Jun Ho Lee
SJSo Yeon Jeon
So Yeon Jeon
DLDong Young Lee
Dong Young Lee
This study aimed to explore the moderating effects of the frequently used cognitive reserve (CR) proxies [i.e., education, premorbid intelligence quotient (pIQ), occupational complexity (OC), and lifetime cognitive activity (LCA)] on the relationships between various in vivo Alzheimer’s disease (AD) pathologies and cognition. In total, 351 [268 cognitively unimpaired (CU), 83 cognitive impaired (CI)] older adults underwent multi-modal brain imaging to measure AD pathologies and cognitive assessments, and information on CR proxies was obtained. For overall participants, only education moderated the relationship between Aβ deposition and cognition. Education, pIQ, and LCA, but not OC, showed moderating effect on the relationship between AD-signature cerebral hypometabolism and cognition. In contrast, only OC had a moderating effect on the relationship between cortical atrophy of the AD-signature regions and cognition. Such moderation effects of the CR proxies were similarly observed in CI individuals, but most of them were not in CU individuals. The findings suggest that the proposed CR proxies have different moderating effects on the relationships between specific AD pathologies and cognition.

1 January 2019 in NeuroImage: Clinical
Verified
Journal Article
Open access
MBMin Soo Byun
Min Soo Byun
HKHyun Jung Kim
Hyun Jung Kim
DYDahyun Yi
Dahyun Yi
HCHyo Jung Choi
Hyo Jung Choi
HBHyewon Baek
Hyewon Baek
DLDong Young Lee
Dong Young Lee
Although previous studies have suggested that insulin plays a role in brain function, it still remains unclear whether or not insulin has a region-specific association with neuronal and synaptic activity in the living human brain. We investigated the regional pattern of association between basal blood insulin and resting-state cerebral glucose metabolism (CMglu), a proxy for neuronal and synaptic activity, in older adults. A total of 234 nondiabetic, cognitively normal (CN) older adults underwent comprehensive clinical assessment, resting-state 18F-fluodeoxyglucose (FDG)-positron emission tomography (PET) and blood sampling to determine overnight fasting blood insulin and glucose levels, as well as apolipoprotein E (APOE) genotyping. An exploratory voxel-wise analysis of FDG-PET without a priori hypothesis demonstrated a positive association between basal blood insulin levels and resting-state CMglu in specific cerebral cortices and hippocampus, rather than in non-specific overall cerebral regions, even after controlling for the effects of APOE e4 carrier status, vascular risk factor score, body mass index, fasting blood glucose, and demographic variables. Particularly, a positive association of basal blood insulin with CMglu in the right posterior hippocampus and adjacent parahippocampal region as well as in the right inferior parietal region remained significant after multiple comparison correction. Conversely, no region showed negative association between basal blood insulin and CMglu. Our finding suggests that basal fasting blood insulin may have association with neuronal and synaptic activity in specific cerebral regions, particularly in the hippocampal/parahippocampal and inferior parietal regions.

23 February 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
KKKang Ko
Kang Ko
DYDahyun Yi
Dahyun Yi
MBMin Soo Byun
Min Soo Byun
JJJoon Hyung Jung
Joon Hyung Jung
NKNayeong Kong
Nayeong Kong
DLDong Young Lee
Dong Young Lee
INTRODUCTION: We investigated the moderating effects of midlife and late‐life cognitive activity (CA) on the relationship between tau pathology and both cognition and cognitive decline. METHODS: Eighty‐nine non‐demented older adults from a Korean cohort underwent comprehensive evaluations, including CA assessments and tau neuroimaging at baseline, and Mini‐Mental State Examination (MMSE) at baseline and the 2‐year follow‐up. RESULTS: Greater midlife CA was associated with higher MMSE scores in a given amount of tau pathology, whereas higher levels of midlife CA were associated with faster tau‐related decline in MMSE scores, particularly in individuals with mild cognitive impairment. Late‐life CA did not exhibit any interaction with tau on either MMSE scores or their 2‐year change. DISCUSSION: Greater midlife CA is generally associated with better cognitive performance despite the presence of tau pathology. However, paradoxically, increased midlife CA appears to be linked to a more rapid tau‐related cognitive decline in already cognitively impaired individuals. Highlights: Greater midlife cognitive activity (CA) was generally associated with better cognitive performance in a given amount of tau pathology. Paradoxically, higher levels of midlife CA were related to a more rapid tau‐related cognitive decline in already cognitively impaired individuals. Late‐life CA did not exhibit any moderation effect on the association between tau and cognitive performance or decline.

1 March 2019 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
JKJee Wook Kim
Jee Wook Kim
MBMin Soo Byun
Min Soo Byun
DYDahyun Yi
Dahyun Yi
JLJun Ho Lee
Jun Ho Lee
KKKang Ko
Kang Ko
DLDong Young Lee
Dong Young Lee
Purpose: We aimed to investigate the relationships of cerebral amyloid beta (Aβ) deposition and neurodegeneration (ND) with subjective memory complaints (SMCs) in cognitively normal (CN) individuals, focusing specially on the modulating effects of vascular risk (VR) on those relationships. Participants and methods: A total of 230 CN elderly individuals underwent comprehensive clinical assessments including the Subjective Memory Complaints Questionnaire (SMCQ), VR assessment, and multimodal brain imaging including [11C] Pittsburgh compound B positron emission tomography (PET), [18F] fluorodeoxyglucose-PET, and magnetic resonance imaging. Results: We found a significant overall positive association between cerebral Aβ retention and SMCQ score. In addition, we found a significant cerebral Aβ retention × VR interaction effect on the SMCQ score. Subgroup analyses showed that the Aβ–SMC association was found only in VR-negative, and not in VR-positive, individuals. We found no relationship between ND and SMCQ. Conclusion: Our findings suggest that SMC in CN elderly individuals reflects early accumulation of Aβ in the brain. Given the modulating effect of VR on the Aβ–SMC relationship, SMC can be used as a meaningful marker of early Aβ deposition in individuals without VR.